Dental Care Clinics in Newton, KS Accepting Medicare
6 Dental Care Clinics found. Showing 1 - 6
 Gregg And Bette Ptrshp Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 301 N Main St, Suite 104, Newton, KS 67114 Phone: 316-283-2690 |
Tippin Dental Group Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 431 Victoria Rd, Newton, KS 67114 Phone: 316-283-2970 Fax: 316-283-5093 |
Dr Pamela R Mccullough Dds Pa Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 229 N Main St, Newton, KS 67114 Phone: 316-283-0870 Fax: 316-282-2500 |
Terry L. Davidson, D.d.s., P.a. Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 120 W 6th St, Newton, KS 67114 Phone: 316-283-0110 Fax: 316-283-0736 |
Sand Creek Family Dental, P.a. Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 400 Allison St, Newton, KS 67114 Phone: 316-283-2273 |
Andrew J. Mettman Dds Llc Dentist - General Practice Medicare: Medicare Enrolled Practice Location: 606 N Main St Ste 102, Newton, KS 67114 Phone: 316-283-0110 Fax: 316-283-0736 |
News Archive
Scientists identify mechanism that may help prostate cancer cells escape effects of cancer drugs
Advanced prostate cancer is a disease notoriously resistant to treatment. New research by scientists at Fred Hutchinson Cancer Research Center and the University of California, San Francisco sheds light on a new mode of drug resistance to emerging therapies in metastatic prostate cancer.
Research brief provides clinical validation of LOXO-101 Phase 1 trial for treatment of TRK fusion cancer
The University of Colorado Cancer Center and Loxo Oncology, Inc., a biopharmaceutical company focused on the discovery, development and commercialization of targeted cancer therapies, today announced the publication of a research brief in the online edition of the journal Cancer Discovery, describing the first patient with a tropomyosin receptor kinase fusion cancer enrolled in the Phase 1 dose escalation trial of LOXO-101, the only selective TRK inhibitor in clinical development.
Research explores links between planet's health and human health
United Nations University will help pioneer a fresh trail in global health research, exploring links between the planet's health and human health at an institute in Kuala Lumpur generously supported by Malaysia.
NTU, Technion announce new collaboration to jointly offer PhD programme
Singapore's leading science and technology university, Nanyang Technological University, and Israel's number one university, Technion-Israel Institute of Technology, today announced a new collaboration to jointly offer a Doctor of Philosophy programme.
USFDA approves Dr. Reddy's ANDA for Fondaparinux Sodium Injection
Dr. Reddy's Laboratories and Alchemia Limited, Brisbane, Australia announced today that Dr. Reddy's has received final approval of Dr. Reddy's ANDA for Fondaparinux Sodium Injection, a bioequivalent generic version of Arixtra, in the US market on July 11, 2011 by the United States Food & Drug Administration.
› Verified 1 days ago